ViaGen – a division of Trans Ova Genetics is the industry’s premier source of cloning technology for all non-primate species. Breeding elite animals requires knowledge, strategy and patience. Today, the use of advanced reproductive technologies like cloning not only capitalizes on scientific advancements in breeding, it allows breeders to further utilize the best tools available to achieve and improve their genetic goals.
ViaGen can help advance genetic opportunities by multiplying the very best in your herd. Breeders of elite animals can use genetic preservation and cloning as the newest tools in their strategic breeding programs. Cloning is a safe, progressive and beneficial means to preserve and extend the best genetics to positively influence future generations. Please utilize this website as a resource to learn more about making the irreplaceable…..replaceable.
ViaGen was founded in Austin, Texas in January 2002 to provide commercial bovine, equine, and porcine genetic preservation and cloning services.
In 2003, ViaGen acquired ProLinia of Athens, Georgia. This acquisition doubled our cloning capacity, gave us the ability to produce clones from cells obtained from carcasses, and provided rights to cloning technologies developed by the Roslin Institute of Edinburgh, Scotland.
In 2007, ViaGen joined forces with Trans Ova Genetics to form the joint venture Bovance, to promote bovine cloning in North America. Trans Ova Genetics has been providing ART (assisted reproductive technologies) to the bovine industry since 1980.
In late 2012, Trans Ova Genetics acquired ViaGen and it became a wholly owned subsidiary of Trans Ova Genetics. Today, all genetic preservation and cloning services, for all non-primate species now falls under ViaGen – a division of Trans Ova Genetics.
ViaGen L.C. is recognized as the global leader in animal genetic preservation and cloning services.